Peter Doshi

University of Maryland - School of Pharmacy

SCHOLARLY PAPERS

1

DOWNLOADS
Rank 113

SSRN RANKINGS

Top 113

in Total Papers Downloads

118,020

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials

Number of pages: 22 Posted: 23 Jun 2022 Last Revised: 09 Sep 2022
Louisiana State University - Lallie Kemp Regional Medical Center, Navarre Health Service, Bond University - Institute for Evidence-Based Healthcare, University of California, Los Angeles (UCLA) - Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles (UCLA), Stanford University and University of Maryland - School of Pharmacy
Downloads 118,020 (7)

Abstract:

Loading...

SARS-CoV-2, COVID-19, Vaccines, COVID-19 vaccines, mRNA vaccines, Pfizer-BioNTech COVID-19 vaccine BNT162b2, Moderna COVID-19 vaccine mRNA-1273, NCT04368728, NCT04470427, serious adverse events, adverse events of special interest, Brighton Collaboration, Coalition for Epidemic Preparedness Innovations, Safety Platform for Emergency